WCN26-7163 Disease activity assessed by glomerular Gd-IgA1 deposition

20260 citationsJournal Articlegold Open Access

Authors

Mai Akimoto · Juntendo University Urayasu Hospital

Kazuaki Mori · Juntendo University

Ryousuke Aoki · Juntendo University

Nozomi Kadota · Juntendo University

Yukako Umezawa · Juntendo University Urayasu Hospital

Tomoyuki Otsuka · Juntendo University Urayasu Hospital

Maiko Nakayama

Abstract

Conclusion:In this single center study, HCQ was well tolerated and effective in lowering proteinuria at 6 months in 28% of non-Chinese patients.Further prospective research in diverse populations and evaluation of ethnicities that may benefit most from HCQ is warranted.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.

Topics & Keywords

Vasculitis and related conditions Renal Diseases and Glomerulopathies Parathyroid Disorders and Treatments

UN Sustainable Development Goals

Zero hunger

Publication Details

Published in: Kidney International Reports

Volume 11, Issue 4, pp. 106288-106288

DOI: 10.1016/j.ekir.2026.106288

Field-Weighted Citation Impact: 0.00